International Collaboration to Guide Value-Based Pricing of Potential Medical Cures

This project will seek to develop, test, and build consensus around an alternative methodology for value-based pricing of potential cures. The study team will address: 1) how to reflect uncertainty in clinical safety and effectiveness in pricing; 2) how to incorporate additional elements of value that are absent from standard cost‐effectiveness methods; and 3) how to reflect lifetime health gains and cost offsets in pricing these cures. Through literature reviews and discussions with U.S. experts and stakeholders as well as officials from international health technology assessment agencies, the team will develop and prioritize a menu of options. It will then run empirical analyses of the alternative methods in various hypothetical cure scenarios. Last, project staff will convene U.S. and international stakeholders to discuss results and develop a roadmap for
value assessment of potential cures.